Filtered By:
Procedure: Coronary Angioplasty
This page shows you your search results in order of date. This is page number 13.
Order by Relevance | Date
Total 3253 results found since Jan 2013.
Differential Impact of Clinical Factors for Predicting High Platelet Reactivity on Clinical Outcomes in Acute Myocardial Infarction Patients Treated With Clopidogrel and Prasugrel
CONCLUSIONS: Clinical factors listed in the HHD-GENE score may help stratify ischemic risks in patients with acute MI treated with clopidogrel and prasugrel, whereas risk stratification without genetic testing in patients treated with clopidogrel may be challenging.PMID:37316266 | DOI:10.5551/jat.64217
Source: Journal of Atherosclerosis and Thrombosis - June 14, 2023 Category: Cardiology Authors: Hiroki Goto Yuichi Saito Tadahiro Matsumoto Takanori Sato Daichi Yamashita Sakuramaru Suzuki Shinichi Wakabayashi Hideki Kitahara Koichi Sano Yoshio Kobayashi Source Type: research
Is It Really Safe to Discontinue Antiplatelet Therapy 12 Months After Percutaneous Coronary Intervention in Patients with Atrial Fibrillation?
AF is the most common cardiac arrhythmia worldwide. The estimated prevalence among adults is 2 –4%, and the lifetime risk of developing AF is one in three individuals.1–3 AF is associated with stroke, increasing the risk four- to five-fold while accounting for 20–30% of ischaemic strokes.4,5 In addition, embolic strokes associated with...
Source: Radcliffe Cardiology - June 13, 2023 Category: Cardiology Authors: dbarot525787 Source Type: research
P2Y12 inhibitor monotherapy versus dual antiplatelet therapy in patients with acute coronary syndromes undergoing coronary stenting: rationale and design of the NEOMINDSET Trial
EuroIntervention. 2023 Jun 12:EIJ-D-23-00125. doi: 10.4244/EIJ-D-23-00125. Online ahead of print.ABSTRACTDual antiplatelet therapy (DAPT) is currently the standard of care after percutaneous coronary intervention (PCI). Recent studies suggest that reducing DAPT to 1-3 months followed by an aspirin-free single antiplatelet therapy (SAPT) strategy with a potent P2Y12 inhibitor is safe and associated with less bleeding. However, to date, no randomised trial has tested the impact of initiating SAPT immediately after PCI, particularly in patients with acute coronary syndromes (ACS). NEOMINDSET is a multicentre, randomised, open...
Source: EuroIntervention - June 12, 2023 Category: Cardiovascular & Thoracic Surgery Authors: Patricia O Guimar ães Marcelo Franken Caio A M Tavares Fabio S Silveira Murillo O Antunes Ricardo R Bergo Rodrigo M Joaquim Jessica C S Hirai Pedro B Andrade Fabio G Pitta Jos é Mariani Bruno R Nascimento Jo ão E T de Paula Marcos S Silveira Tiberio A Source Type: research
Clinical outcomes of different revascularization approaches for patients with multi-vessel coronary artery disease: A network meta-analysis
CONCLUSIONS: ONCABG shows a better rank probability compared to all other techniques for preventing TVR, while RCAB offers greater freedom from most postoperative complications. However, given the absence of randomized controlled trials, these results should be interpreted with caution.PMID:37294619 | DOI:10.1177/02676591231182585
Source: Perfusion - June 9, 2023 Category: Cardiovascular & Thoracic Surgery Authors: Syed Umar Hasan Alina Pervez Muhammad Wahdan Naseeb Bakhtawar Saleem Rajput Ariba Faheem Irbaz Hameed Michel Pompeu S á M Mujeeb Zubair Source Type: research
Association of preoperative clinical frailty and clinical outcomes in elderly patients with stable coronary artery disease after percutaneous coronary intervention
AbstractThere are few reports on the long-term clinical outcome after percutaneous coronary intervention (PCI) in patients with stable coronary artery disease (CAD) complicated with frailty. This novel study investigated the association between pre-PCI frailty and long-term clinical outcomes in elderly patients aged 65 years or older with stable CAD who underwent elective PCI. We assessed 239 consecutive patients aged 65 years or older with stable CAD who underwent successful elective PCI at Kagoshima City Hospital between January 1st, 2017 and December 31st, 2020. Frailty was retrospectively assessed using the Canadian...
Source: Heart and Vessels - June 7, 2023 Category: Cardiology Source Type: research
Clinical characteristics, risk factors, and prognostic analyses of coronary small vessel disease: a retrospective cohort study of 986 patients
CONCLUSION: Compared to non-CSVD, CSVD was associated with more complex lesions, had worse revascularization efficacy, and a poorer prognosis.PMID:37259582 | DOI:10.1080/00325481.2023.2221110
Source: Postgraduate Medicine - June 1, 2023 Category: Internal Medicine Authors: Yue Chen Xiao Cui Liujun Jiang Xiaolei Xu Chaoyang Huang Qiwen Wang Source Type: research
Implications of left atrial volume index in patients with three-vessel coronary disease: A 6.6-year follow-up cohort study
CONCLUSIONS: LAVI is a potential index for risk stratification and therapeutic decision-making in patients with three-vessel coronary disease. CABG is associated with improved long-term outcomes compared with MT alone, regardless of LAVI quartiles. When LAVI is severely elevated, PCI is associated with higher risk of cardiac death than CABG.PMID:37262047 | DOI:10.1097/CM9.0000000000002723
Source: Chinese Medical Journal - June 1, 2023 Category: General Medicine Authors: Ru Liu Lei Song Ce Zhang Lin Jiang Jian Tian Lianjun Xu Xinxing Feng Linyuan Wan Xueyan Zhao Ou Xu Chongjian Li Runlin Gao Rutai Hui Wei Zhao Jinqing Yuan Source Type: research
Clinical characteristics, risk factors, and prognostic analyses of coronary small vessel disease: a retrospective cohort study of 986 patients
CONCLUSION: Compared to non-CSVD, CSVD was associated with more complex lesions, had worse revascularization efficacy, and a poorer prognosis.PMID:37259582 | DOI:10.1080/00325481.2023.2221110
Source: Postgraduate Medicine - June 1, 2023 Category: Internal Medicine Authors: Yue Chen Xiao Cui Liujun Jiang Xiaolei Xu Chaoyang Huang Qiwen Wang Source Type: research
